A detailed history of Mesirow Financial Investment Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 16,003 shares of LLY stock, worth $12.9 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
16,003
Previous 15,892 0.7%
Holding current value
$12.9 Million
Previous $14.4 Million 1.47%
% of portfolio
0.29%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$772.14 - $960.02 $85,707 - $106,562
111 Added 0.7%
16,003 $14.2 Million
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $11.5 Million - $14.4 Million
15,892 New
15,892 $14.4 Million
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $9.55 Million - $12.8 Million
16,120 New
16,120 $12.5 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $7.65 Million - $9.02 Million
14,572 New
14,572 $8.49 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.